- The antidepressant fluvoxamine could keep mild COVID-19 from worsening https://www.sciencenews.org/article/covid-19-coronavirus-antidepressant-fluvoxamine-treatment 4 comments science
Linking pages
- The antidepressant fluvoxamine can reduce COVID-19 hospitalizations | Science News https://www.sciencenews.org/article/covid-antidepressant-fluvoxamine-drug-hospital-death 2244 comments
- Why it’s still so hard to find treatments for early COVID-19 https://www.sciencenews.org/article/coronavirus-covid-19-why-early-treatment-drugs 0 comments
Linked pages
- The antidepressant fluvoxamine can reduce COVID-19 hospitalizations | Science News https://www.sciencenews.org/article/covid-antidepressant-fluvoxamine-drug-hospital-death 2244 comments
- Association of COVID-19 Vaccination with Risk of Medically-Attended Post-Acute Sequelae of COVID-19 During the Ancestral, Alpha, Delta, and Omicron Variant Eras | Open Forum Infectious Diseases | Oxford Academic https://academic.oup.com/ofid/advance-article/doi/10.1093/ofid/ofab358/6316214 179 comments
- Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19: A Randomized Clinical Trial | Critical Care Medicine | JAMA | JAMA Network https://jamanetwork.com/journals/jama/fullarticle/2773108 126 comments
- Log In ‹ STOP COVID Trial — WordPress https://stopcovidtrial.wustl.edu/ 0 comments
- COVID-19 Early Treatment Fund http://www.treatearly.org 0 comments
Related searches:
Search whole site: site:sciencenews.org
Search title: Antidepressant fluvoxamine could keep mild COVID-19 from worsening | Science News
See how to search.